Stockscreener 앱 받기
30.69
3.26%
0.97
시간 외 거래:
30.69
Alamar Biosciences Inc (ALMR) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 |
| 기간 | 3개월 | 3개월 |
| Revenues |
13.03%
29.43
|
26.04 |
| Cost Of Revenue |
1.13%
11.71
|
11.58 |
| Gross Profit |
22.56%
17.72
|
14.46 |
Operating Expenses
|
16.59%
31.25
|
26.80 |
| Depreciation and Amortization |
2.83%
1.134
|
1.167 |
| Operating Income/Loss |
9.60%
-13.53
|
-12.35 |
| Income/Loss From Continuing Operations Before Tax |
36.28%
-13.29
|
-20.86 |
| Income Tax Expense/Benefit |
120.04%
-0.093
|
0.464 |
| Net Income/Loss |
38.11%
-13.20
|
-21.32 |
| Basic Average Shares |
378.52%
58.67
|
12.26 |
| Diluted Average Shares |
378.52%
58.67
|
12.26 |
| Basic Earnings Per Share |
87.36%
-0.22
|
-1.74 |
| Diluted Earnings Per Share |
87.36%
-0.22
|
-1.74 |
2.13%
3.76%
자본화:
|
볼륨(24시간):